🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We show how age can be predicted from handheld #POCUS using #ai and 2 views (PLAX and AP4C)! Age prediction ≥ 5 years of chronological age was associated with 34% increased risk of death. Read: bit.ly/4dzpIp8 JASE Kobi Faierstein Eric Topol @drpaulfriedman

Happy to take part in this interesting work! It clearly demonstrates how AI is slowly being integrated into clinical medicine, with the potential to shed light on the "unknowns". Elad Maor

You've probably heard "don't give lactated ringers because it raises lactate" This statement is ~98% false, but there's one crucial practice-changing fact that you need to know. A 🧵 all about lactic acid and lactated ringers! 1/

Free for 50 days—review on Structural Cardiac Interventions in Patients with Heart Failure: authors.elsevier.com/a/1jdIG2d9GH%7… Joann Lindenfeld Dan Burkhoff MD PhD Michael Mack, MD JACC Journals American College of Cardiology European Society of Cardiology HFSA Dr. Gilbert Tang Cardiovascular Research Foundation

Challenging fellows case at #THT2025 with Dor Lotan, MD ChonyAlbert MD Gavin Hickey David T Majure, MD #KanikaMody

How do you manage Lung CA post OHT and other cases of early malignancy post OHT? Register to hear about approaches to these challenging cases and more at the 2025 Columbia Cardio-Oncology symposia this Friday Feb 28th 2025 🔗 eventleaf.com/Attendee/Atten… Dor Lotan, MD Jayant Raikhelkar

We start the Implementation Science session on Improving LVAD patient care with Dor Lotan, MD presenting the preliminary results of the RAMP IT UP 3 study #ISHLT2025

Rockstar Dor Lotan, MD presenting primary results from the Ramp It Up 3 study at The ISHLT #ISHLT2025 late breaking clinical science session 💪🏻💪🏻💪🏻 Nir Uriel, MD MSc Gabriel Sayer ColumbiaCardiology

Dor Lotan, MD There was a reduction in the frequency of diuretic changes during follow-up, mostly occurring during the first two quarters

Dor Lotan, MD Patients had an increased "in-range" PAd, improved step count, 6 minute walk test, better quality of life despite reduction in Compliance with daily PA monitoring #ISHLT2025 The ISHLT

The formidable Boaz elad presenting findings on the impact of Impella support pre-dVAD on de-novo AI development. Phenomanel job! The ISHLT #ISHLT2025 Nir Uriel, MD MSc Gabriel Sayer ColumbiaCardiology 1/2

📢 Join us at the 1st Annual Cardio-Rheumatology Symposium 🫀 📍Columbia University, NYC 🗓️ May 30, 2025 From inflammation to imaging, autoimmunity to atherosclerosis—don’t miss top experts like Ridker, Cooper, Maurer & Bathon! columbiamedicinecme.org/Attendee/Atten… Columbia Medicine NewYork-Presbyterian

Electrostatic discharge may lead to complete HeartMate 3 pump stoppage—awareness and education can prevent this serious complication Nir Uriel, MD MSc @ersied727 Dor Lotan, MD Ilan Richter @ELadBoaz #AHAJournals ahajrnls.org/4k5jb8h

Join us for our ‘#CardioRheumatology Symposium: Inflammatory Cardiac & #CardiovascularDisease' - a virtual and in-person program on Friday, May 30, 2025. 7.25 ACCME Credits. ColumbiaMedicineCME.org #Myocarditis #Rheumatology #Cardiology #Immunotherapy

📣Calling all #AHFTC Fellows! Circ: Heart Failure is proud to launch a free educational webinar series for current or past AHFTC fellows. 📍8 live virtual sessions, 1 in-person event 📍New topic each session 📅Start Date: August 13, 2025 🔗Learn More: ahajournals.org/circheartfailu…

Everything you want to know about belatacept therapy in heart transplant recipients Our experience now in JHLT ColumbiaCardiology Excellent work from ⭐️ fellow Dr. Julia Baranowska! Gabriel Sayer 📎 jhltonline.org/article/S1053-…

Current state of TR evaluation, management and direction of potential interventions in patients with LVADs Can transcather therapies help alleviate late RVF in select candidates? Now in JACC Journals, our review led by Boaz elad Gabriel Sayer Dan Burkhoff MD PhD RTHahnMD Dor Lotan, MD

Our latest at JHLT Correlation between dd-cfDNA and MMDx in HTx undergoing for-cause endomyocardial biopsies MMDx detected rejection 4x > than histology when dd-cfDNA was elevated—mainly ABMR 📈 dd-cfDNA AUC 0.89 📌 Opt=0.26% 🔗 shorturl.at/90qF5 #CardioX